Hepatitis Monthly

Published by: Kowsar

Hepatitis B Seroprevalence and the Relationship Between Being Hepatitis B Vaccinated and Infected with Social Determinants of Health: Manisa, 2014

Hilal Gorgel Kahraman 1 , * , Ozgen Alpay Ozbek 2 , Mestan Emek 3 , Gonca Atasoylu 4 , Ozgur Sekreter 4 and Belgin Unal 5
Authors Information
1 Narlidere Health Directorate, Izmir, Turkey
2 Dokuz Eylul University Medical Faculty, Department of Medical Microbiology, Izmir, Turkey
3 Antalya Public Health Directorate, Antalya, Turkey
4 Manisa Public Health Directorate, Manisa, Turkey
5 Dokuz Eylul University Medical Faculty, Department of Public Health, Izmir, Turkey
Article information
  • Hepatitis Monthly: July 2018, 18 (7); e65395
  • Published Online: June 30, 2018
  • Article Type: Research Article
  • Received: December 21, 2017
  • Revised: May 10, 2018
  • Accepted: May 19, 2018
  • DOI: 10.5812/hepatmon.65395

To Cite: Kahraman H G, Ozbek O A, Emek M, Atasoylu G, Sekreter O, et al. Hepatitis B Seroprevalence and the Relationship Between Being Hepatitis B Vaccinated and Infected with Social Determinants of Health: Manisa, 2014, Hepat Mon. 2018 ; 18(7):e65395. doi: 10.5812/hepatmon.65395.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. World Health Organization . Global health sectors strategy on viral hepatitis 2016-2021 towards ending viral hepatitis. Geneva, Switzerland: WHO Document Production Services; 2016. Available from: http://www.who.int/iris/handle/10665/246177.
  • 2. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546-55. doi: 10.1016/S0140-6736(15)61412-X. [PubMed: 26231459].
  • 3. Ott JJ, Horn J, Krause G, Mikolajczyk RT. Time trends of chronic HBV infection over prior decades - A global analysis. J Hepatol. 2017;66(1):48-54. doi: 10.1016/j.jhep.2016.08.013. [PubMed: 27592304].
  • 4. Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca U, et al. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clin Microbiol Infect. 2015;21(11):1020-6. doi: 10.1016/j.cmi.2015.06.028. [PubMed: 26163105].
  • 5. Toy M, Onder FO, Wormann T, Bozdayi AM, Schalm SW, Borsboom GJ, et al. Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC Infect Dis. 2011;11:337. doi: 10.1186/1471-2334-11-337. [PubMed: 22151620]. [PubMed Central: PMC3262158].
  • 6. Ozmert EN. Progress in the national immunization practices in the world and in Turkey. Cocuk Sagligi ve Hastalikari Dergisi. 2008;51(168-75).
  • 7. World Health Organization . WHO-UNICEF estimates of HepB3 coverage. 2017. Available from: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragehepb3.html.
  • 8. Stuver SO, Boschi-Pinto C, Trichopoulos D. Infection with hepatitis B and C viruses, social class and cancer. IARC Sci Publ. 1997;(138):319-24. [PubMed: 9353672].
  • 9. World Health Organization . Measurement and targets, final report of the task group on measurement and targets, review of social determinants of health and the health divide in the WHO European region. Copenhagen: WHO Regional Office for Europe; 2016. Available from: http://www.euro.who.int/__data/assets/pdf_file/0004/302872/M-and-T-TG-final-report.pdf?ua=1.
  • 10. Boratav K. Class Profiles form Istanbul and Anatolia. 2nd ed. Ankara: Imge Publisher; 2004.
  • 11. Lubrano M. The econometrics of inequality and poverty Lecture 8: Equivalence scales. 2016. Available from: http://www.vcharite.univ-mrs.fr/PP/lubrano/cours/Lecture-8.pdf.
  • 12. Dominguez-Almendros S, Benitez-Parejo N, Gonzalez-Ramirez AR. Logistic regression models. Allergol Immunopathol (Madr). 2011;39(5):295-305. doi: 10.1016/j.aller.2011.05.002. [PubMed: 21820234].
  • 13. Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC. What level of hepatitis B antibody is protective? J Infect Dis. 1999;179(2):489-92. doi: 10.1086/314578. [PubMed: 9878036].
  • 14. Banatvala JE, Van Damme P. Hepatitis B vaccine -- do we need boosters? J Viral Hepat. 2003;10(1):1-6. [PubMed: 12558904].
  • 15. Lu S, Ren J, Li Q, Jiang Z, Chen Y, Xu K, et al. Effects of hepatitis B vaccine boosters on anti-HBs-negative children after primary immunization. Hum Vaccin Immunother. 2017;13(4):903-8. doi: 10.1080/21645515.2016.1260794. [PubMed: 27905821]. [PubMed Central: PMC5404365].
  • 16. Chiara F, Bartolucci GB, Cattai M, Piazza A, Nicolli A, Buja A, et al. Hepatitis B vaccination of adolescents: significance of non-protective antibodies. Vaccine. 2013;32(1):62-8. doi: 10.1016/j.vaccine.2013.10.074. [PubMed: 24188755].
  • 17. Poorolajal J, Hooshmand E. Booster dose vaccination for preventing hepatitis B. Cochrane Database Syst Rev. 2016;(6). CD008256. doi: 10.1002/14651858.CD008256.pub3. [PubMed: 27271960].
  • 18. Buran T, Tosun S, Aksu S, Koroglu G, Eskicioglu F, Kasirga E. The importance of vaccination of child, adolescent and young adult age groups in fighting against HBV Infection. CBU-SBED. 2015;2(1):16-8.
  • 19. Ertekin V, Selimoglu MA, Altinkaynak S. Sero-epidemiology of hepatitis B infection in an urban paediatric population in Turkey. Public Health. 2003;117(1):49-53. [PubMed: 12802905].
  • 20. Tajiri K, Shimizu Y. Unsolved problems and future perspectives of hepatitis B virus vaccination. World J Gastroenterol. 2015;21(23):7074-83. doi: 10.3748/wjg.v21.i23.7074. [PubMed: 26109794]. [PubMed Central: PMC4476869].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments